The Global Alcohol Policy Conference (GAPC2023), “Investing in People before Profits: Building Momentum towards the Framework Convention on Alcohol Control,” will be held from 24 - 26 October 2023 in Cape Town, South Africa with pre...
The National Dangerous Drugs Control Board have proudly planned to conduct an International Symposium on Drug-Related Studies 2022 will be held from 1st and 2nd December 2022 in Colombo, Sri Lanka to facilitate the exchange of information...
Mpanza, D.M., Govender, P. & Voce, A. Perspectives of service providers on aftercare service provision for persons with substance use disorders at a Rural District in South Africa. Subst Abuse Treat Prev Policy 17, 60 (2022). https://doi.org/10.1186/s13011-022-00471-5
Background
Aftercare programs for people with substance use disorders (PWSUD) are frequently challenged with a number of overlapping obstacles, including uncertain policy consequences and a lack of resources. Despite demographic variety, service providers in South Africa are obligated to offer aftercare programs that effectively reintegrate people with PWSUD into society, the workforce, family, and community life, as specified by Act No. 70 of 2008. Little is known about the availability of aftercare services in South Africa, particularly in rural areas. This paper investigates service...
د جنوبی افریقا د الکولو او نشه یی توکو د اعتیاد ملی شورا (SANCA) چې د ISSUP جنوبی افریقا کوربه سازمان دی په دې وروستیو کې د "نشه یی توکو د استعمال د بې نظمۍ درملنه بربنډول" تر عنوان لاندې د نړۍ په کچه یو بل نوښتګر کنفرانس کوربه وو.
Hirchak, K.A., Amiri, S., Kordas, G. et al. Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes. Subst Abuse Treat Prev Policy 17, 41 (2022). https://doi.org/10.1186/s13011-022-00457-3
Background
Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for opioid use disorder (MOUD; e.g., buprenorphine) are effective, evidence-based treatments that can be delivered in office-based primary care settings. We investigated disparities in the proportion of national prescribers who have obtained a waiver issued to prescribe MOUD by demographic characteristics.
Substance-Use-Disorder (SUD) professionals often find themselves immersed in their work and as a consequence may not notice the ground-breaking developments which are happening around us. As initial-contact and treatment professionals, it is important that we invest sufficiently in our knowledge and understanding of new developments and the opportunities these may present.
For this purpose, the Addiction Practitioners Forum has been created by the South African National Council on Alcoholism and Drug Dependence (SANCA National) to close the gap between practice and theory. SANCA National has...
EUSPR 2022 are pleased to announce that the 13th EUSPR Conference will be held in Tallinn, Estonia on 29th and 30th September 2022, with workshops and project meetings scheduled for the pre-conference day, September 28th.
Harker, N., Johnson, K., Erasmus, J. et al. COVID 19—impact on substance use treatment utilization and provision in South Africa. Subst Abuse Treat Prev Policy 17, 15 (2022). https://doi.org/10.1186/s13011-022-00446-6
Background
The coronavirus disease 2019 (COVID-19) pandemic has affected persons suffering from substance use disorders (SUDs) all around the world. The purpose of this study was to investigate changes in the number of SUD treatment episodes provided during the pandemic's peak, as well as SUD treatment providers' perceptions of the impact of COVID-19-related restrictions on people with SUDs and the delivery of SUD treatment services in South Africa.
Methods
We used administrative data collected as part of the South African Community Epidemiology Network on Drug Use (SACENDU) project to...
The Commission on Narcotic Drugs is starting very soon! In fact, tomorrow, Monday, 14 March 2022.
Once again, all sessions, as well as the side events, are to be held online due to the pandemic. The good thing about that means that, you can still follow the plenaries and the side events! That’s why we thought that you might appreciate having all the links in one place.
Hybrid effectiveness-implementation trial designs have become increasingly prevalent in implementation research. As hybrid designs enter their second decade of widespread use, the Frontiers in Health Services’ Implementation Science section launches a Research Topic to fuel the field’s discourse on the past, present, and future of hybrid designs in knowledge translation. Submissions are welcome of both Original and/or Brief Research, Review, Methods, and Perspective articles. The call addresses critical assessments of hybrid designs, innovative use of hybrid designs in current trials, and...